How long is the critical period for intracerebral hemorrhage?

　　Intracerebral hemorrhage (ICH) is a common cardiovascular and cerebrovascular disease, often associated with high rates of mortality or disability. Middle-aged and elderly individuals—particularly those at high risk for ICH—may experience a sudden rise in blood pressure and other related symptoms. However, many people refer to a “critical period” following ICH. So, how long does this critical period last?

　　How Long Is the Critical Period Following Intracerebral Hemorrhage?

　　The critical period after intracerebral hemorrhage lasts at least three weeks. During this time, patients face risks including rebleeding, cerebral edema, and associated complications. First, the most common timeframe for rebleeding is within 72 hours after the initial hemorrhage; beyond this window, the risk of rebleeding declines significantly. Second, the second critical phase is the cerebral edema period. Cerebral edema primarily results from compression of surrounding brain tissue by the hematoma, leading to ischemia, hypoxia, and swelling of brain cells. Edema typically develops 3–5 days post-hemorrhage and begins to resolve around one week later. In patients with large-volume hemorrhages, edema may persist for up to two weeks. Finally, the complication phase follows, with major complications including pulmonary infection, intracranial infection, and deep vein thrombosis (DVT) of the lower limbs. The peak incidence of these complications occurs around three weeks, thus defining the approximate duration of the critical period as three weeks.

　　First, aggressive management includes dehydration therapy, diuretics, and administration of human serum albumin to reduce intracranial pressure (ICP). This helps prevent further functional impairment of brain tissue—or life-threatening brain herniation—caused by elevated ICP following hemorrhage. For patients with large-volume hemorrhage, marked cerebral edema, significant mass effect, or impaired consciousness, surgical evacuation of the hematoma should be considered; in severe cases, craniectomy may be necessary to rapidly lower ICP and save lives. Rapid progression to coma after ICH frequently precipitates pulmonary infection; if awakening is delayed, early tracheostomy is recommended to maintain airway patency, along with proactive, scheduled anti-infective therapy. Close monitoring of consciousness level and pupillary response—as well as serial cranial CT scans—is essential both before and after surgery to detect and prevent potentially fatal hematoma expansion.

　　Patients are advised to seek prompt medical treatment upon symptom onset. We hope this information proves helpful.